Clinical Trial

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life. This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).
Trial Details
NCT Number NCT07539038
Lead Sponsor Centro di Riferimento Oncologico - Aviano
Conditions Breast Cancer
Enrollment 44 participants
Start Date 2025-04-03
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-20